Application of contrast-enhanced ultrasonography in evaluating obstructive renal injury

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200058953

Enrollment

Unknown

Registered

2022-04-20

Start date

2022-05-01

Completion date

Unknown

Last updated

2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive nephropathy (injury)

Interventions

Gold Standard:DTPA (99MTc-diethylenetriamine pentaacetic acid nephrography)

Index test:Enhanced ultrasound venography

Eligibility

Sex/Gender

All

Age

0.3 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Urinary tract obstruction diseases such as UPJO, UVJO, PUV; 2. No history of surgical treatment.

Exclusion criteria

Exclusion criteria: 1. Complicated with other abnormalities of urinary system; 2. Allergic to sulfur hexafluoride microspheres or SonoVue; 3. Right-left shunt heart disease; 4. Severe pulmonary hypertension (pulmonary arterial pressure > 90 mmHg).

Design outcomes

Primary

Measure	Time frame
sensitivity;specificity;area under the ROC curve;	—

Countries

China

Contacts

Public ContactLi Changpei

Xiamen Hospital, Affiliated Pediatric Hospital of Fudan University; Xiamen Children's Hospital

etyy6161@126.com+86 592 2529591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026